查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1268814

3D 生物打印市場規模、份額、趨勢分析報告，按技術（磁懸浮、基於噴墨）、按應用（醫療、牙科、生物傳感器、生物墨水）、按地區、細分趨勢，2023-2030 年

3D Bioprinting Market Size, Share & Trends Analysis Report By Technology (Magnetic Levitation, Inkjet-based), By Application (Medical, Dental, Biosensors, Bioinks), By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 109 Pages | 商品交期: 2-10個工作天內

價格

3D 生物打印市場增長和趨勢：

Grand View Research, Inc. 的最新報告預測，到 2030 年全球 3D 生物打印市場規模將達到 53 億美元，預測期內以 12.5% 的複合年增長率擴張。

COVID-19 病例的增加和慢性病的高患病率是促進增長的主要因素。 在大流行期間，3D 打印已成為改善醫療保健和支持應急響應的關鍵技術。

自 2019 年 12 月在中國首次發現以來，COVID-19 流行病一直呈上升趨勢。 截至 2021 年 1 月 12 日，全球已報告超過 9150 萬例 COVID-19 病例，超過 1,956,880 例死亡。 大流行加速了疫苗和藥物試驗的開發。

與此同時，各3D生物打印公司都在專注於人造組織的研發。 使用 U-FAB 和其他生物打印技術，CLECELL 創造了工程呼吸上皮細胞，利用粘膜纖毛升降機來防止感染和組織損傷。

大流行不僅影響了人們的福祉，還影響了全球經濟和各種醫療保健基礎設施。 它還嚴重擾亂了全球醫療設備和藥品的供應鏈。 在這樣的危機中，各種 3D 生物打印公司發起了一項全球運動，為醫護人員提供緊急醫療設備，例如呼吸機和個人防護設備 (PPE)。

北美將在 2022 年佔據約 30.9% 的最高份額。 越來越多地採用 3D 生物打印來製造醫療產品預計將成為促進該地區市場增長的主要因素之一。 另一方面，亞太地區有望在製藥和生物製藥領域看到更多的技術發展。

3D 生物打印市場報告亮點

  • 由於研發投資增加，醫療行業將在 2022 年佔據最大份額，達到 37.6%。
  • 由於技術發展和各種創新者越來越多地採用磁懸浮技術，磁懸浮部分預計在預測期內將實現 13.7% 的最高複合年增長率。
  • 北美在 2022 年以 30.9% 的份額主導了市場。 增加政府對醫療保健行業的支出是推動該地區市場的主要因素之一。

內容

第一章研究方法論

  • 市場細分和範圍
  • 市場定義
  • 信息採購
    • 購買的數據庫
    • GVR 內部數據庫
    • 輔助技術和第三方視角
    • 初步調查
  • 信息分析
    • 數據分析模型
  • 市場形成和數據可視化
  • 驗證和發布數據

第 2 章執行摘要

第 3 章行業展望：市場變量、趨勢和範圍

  • 市場細分和範圍
  • 市場規模和增長前景
  • 3D 生物打印市場：市場動態
    • 市場驅動力分析
      • 3D 生物打印行業的技術進步
      • 慢性病患病率上升
      • 越來越多地使用 3D 生物打印在製藥和美容領域
    • 市場製約因素分析
      • 3D 生物打印機的高成本
      • 缺乏訓練有素的專業人員
  • 行業分析 - 搬運工
    • 供應商力量
    • 買家的議價能力
    • 替代威脅
    • 新進入者的威脅
    • 競爭公司之間的敵對關係
  • 3D 生物打印 - SWOT 分析（通過 PEST）
    • 政治形勢
    • 經濟狀況
    • 社交情況
    • 技術概況
  • 新型冠狀病毒影響分析

第 4 章 3D 生物打印市場：技術估計和趨勢分析

  • 全球 3D 生物打印市場：技術波動分析
  • 磁懸浮技術
  • 噴墨技術
  • 基於注射器的技術
  • 激光技術
  • 其他

第 6 章 3D 生物打印市場：應用估計和趨勢分析

  • 全球 3D 生物打印市場：應用波動分析
  • 醫療
    • 組織和器官的產生
    • 藥丸
    • 假肢和植入物
    • 其他
  • 牙科
  • 生物傳感器
  • 消費者/個人產品測試
  • 生物墨水
  • 食品和動物產品

第 7 章 3D 生物打印市場：按服務、技術和應用分類的區域估計和趨勢分析

  • 2022 年和 2030 年按地區劃分的 3D 生物打印市場份額
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 意大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 泰國
    • 澳大利亞
    • 韓國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
  • 中東和非洲 (MEA)
    • 南非
    • 沙特阿拉伯
    • 阿拉伯聯合酋長國
    • 科威特

第八章競爭格局

  • 公司簡介
    • Envisiontec, Inc.
      • 公司簡介
      • 產品基準
      • 戰略舉措
    • 有機體
      • 公司簡介
      • 財務業績
      • 產品基準
      • 戰略舉措
    • Inventia Life Sciences Pty Ltd
      • 公司簡介
      • 產品基準
    • POIETIS
      • 公司簡介
      • 產品基準
      • 戰略舉措
    • VIVAX BIO, LLC
      • 公司簡介
      • 產品基準
      • 戰略舉措
    • ALLEVI
      • 公司簡介
      • 產品基準
    • Cyfuse Biomedical KK
      • 公司簡介
      • 產品基準
      • 戰略舉措
    • 3D 生物打印解決方案
      • 公司簡介
      • 產品基準
    • CELLINK 全球
      • 公司簡介
      • 財務業績
      • 產品基準
      • 戰略舉措
    • REGEMAT 3D SL
      • 公司簡介
      • 產品基準
Product Code: 978-1-68038-636-3

3D Bioprinting Market Growth & Trends:

The global 3D bioprinting market size is expected to reach USD 5.3 billion by 2030, expanding at a CAGR of 12.5% over the forecast period, according to a new report by Grand View Research, Inc. Rising cases of COVID-19 and high prevalence of chronic diseases are some of the major factors contributing to the growth. During the outbreak of the pandemic, 3D printing has stepped up to become a vital technology to support improved healthcare and emergency response.

The COVID-19 epidemic is ever increasing since it was first identified in China in December 2019. Until January 12, 2021, more than 91.5 million cases of COVID-19 were reported globally, with more than 1,956,880 deaths, across the globe. This pandemic has fast-tracked the development of vaccine and drug testing.

In the meantime, various 3D bioprinting companies are focused on the R&D of artificial tissues. With the help of U-FAB and other bioprinting technologies, CLECELL company has created respiratory epithelium artificial tissue which will help to prevent infection and tissue injury through the use of the mucociliary elevator.

The pandemic not only affected the well-being of people, but also affected the economy, and various other healthcare infrastructures worldwide. It severely disrupted the medical devices and pharmaceutical supply chains across the world. In such critical situations, various 3D bioprinting companies have created a global movement to supply emergency medical equipment such as ventilators, and personal protection equipment (PPE), to healthcare workers.

North America held the highest share of about 30.9% in 2022. Increasing adoption of 3D bioprinting for the production of medical products is expected to be one of the major factors contributing to market growth in this region. Whereas, Asia Pacific is anticipated to witness increased technological development in the pharmaceutical and biopharmaceutical sectors.

3D Bioprinting Market Report Highlights:

  • The medical segment accounted for the largest share of 37.6% in 2022 due to the increasing investment made in R&D
  • The magnetic levitation segment is anticipated to witness the highest CAGR of 13.7% over the forecast period due to technological development, and increasing adoption of magnetic levitation techniques by various innovators
  • North America dominated the market in 2022 with a share of 30.9%. Growing government expenditure on the healthcare industry is one of the major factors driving the market in this region
  • Some of the key players include Organovo; Envision TEC; Inventia Life Science PTY LTD; Poietis; Vivax Bio, LLC; Allevi; Cyfuse Biomedical K.K.; 3D Bioprinting Solutions; Cellink Global; Regemat 3D S.L.

Table of content

Chapter 1 Research Methodology

  • 1.1 Market Segmentation & Scope
  • 1.2 Market Definition
  • 1.3 Information Procurement
    • 1.3.1 Purchased database
    • 1.3.2 GVR's internal database
    • 1.3.3 Secondary technology & third party perspectives
    • 1.3.4 Primary research
  • 1.4 Information Analysis
    • 1.4.1 Data analysis models
  • 1.5 Market Formulation & Data Visualization
  • 1.6 Data Validation & Publishing

Chapter 2 Executive Summary

  • 2.1 3D Bioprinting Market Outlook, 2018 - 2030

Chapter 3 Industry Outlook: Market Variables, Trends, & Scope

  • 3.1 Market Segmentation and Scope
  • 3.2 Market Size and Growth Prospects
  • 3.3 3D Bioprinting Market: Market Dynamics
    • 3.3.1 Market driver analysis
      • 3.3.1.1 Technological advancement in the 3d bioprinting industry
      • 3.3.1.2 Rising prevalence of chronic disease
      • 3.3.1.3 Increasing use of 3d bioprinting in the pharmaceutical and cosmetology
    • 3.3.2 Market restraint analysis
      • 3.3.2.1 The high cost of 3D bioprinters
      • 3.3.2.2 Lack of trained professionals
  • 3.4 Industry Analysis - Porter's
    • 3.4.1 Supplier Power
    • 3.4.2 Buyer Power
    • 3.4.3 Substitution Threat
    • 3.4.4 New Entrants Threat
    • 3.4.5 Competitive Rivalry
  • 3.5 3D Bioprinting-SWOT Analysis, By PEST
    • 3.5.1 Political landscape
    • 3.5.2 Economic landscape
    • 3.5.3 Social landscape
    • 3.5.4 Technology landscape
  • 3.6 Covid Impact Analysis

Chapter 4 3D Bioprinting Market: Technology Estimates & Trend Analysis

  • 4.1 Global 3D Bioprinting Market: Technology Movement Analysis
  • 4.2 Magnetic Levitation Technology
    • 4.2.1 Global Magnetic Levitation technology market, 2018 - 2030 (USD Million)
  • 4.3 Inkjet-based Technology
    • 4.3.1 Global Inkjet-based technology market, 2018 - 2030 (USD Million)
  • 4.4 Syringe-based Technology
    • 4.4.1 Global Syringe-based technology market, 2018 - 2030 (USD Million)
  • 4.5 Laser-based Technology
    • 4.5.1 Global Laser-based technology market, 2018 - 2030 (USD Million)
  • 4.6 Others
    • 4.6.1 Global Other technologies market, 2018 - 2030 (USD Million)

Chapter 6 3D Bioprinting Market: Application Estimates & Trend Analysis

  • 6.1 Global 3D Bioprinting Market: Application Movement Analysis
  • 6.2 Medical
    • 6.2.1 Global medical market, 2018 - 2030 (USD Million)
    • 6.2.2 Tissue and organ generation
      • 6.2.2.1 Global tissue and organ generation market, 2018 - 2030 (USD Million)
    • 6.2.3 Medical pills
      • 6.2.3.1 Global Medical pills market, 2018 - 2030 (USD Million)
    • 6.2.4 Prosthetics and implants
      • 6.2.4.1 Global Prosthetics and implants market, 2018 - 2030 (USD Million)
    • 6.2.5 Others
      • 6.2.6.1 Global others application market, 2018 - 2030 (USD Million)
  • 6.3 Dental
    • 6.3.1 Global dental market, 2018 - 2030 (USD Million)
  • 6.4 Biosensors
    • 6.4.1 Global biosensors market, 2018 - 2030 (USD Million)
  • 6.5 Consumer/Personal Product Testing
    • 6.5.1 Global consumer/personal product testing market, 2018 - 2030 (USD Million)
  • 6.6 Bioinks
    • 6.6.1 Global bioinks market, 2018 - 2030 (USD Million)
  • 6.7 Food and Animal Product
    • 6.7.1 Global food and animal market, 2018 - 2030 (USD Million)

Chapter 7 3D Bioprinting Market: Regional Estimates & Trend Analysis, by Service, Technology, & Application

  • 7.1 3D Bioprinting Market Share By Region, 2022 & 2030
  • 7.2 North America
    • 7.2.1 North America 3D Bioprinting market, 2018 - 2030 (USD Million)
    • 7.2.2 U.S.
      • 7.2.2.1 U.S. 3D Bioprinting market, by technology, 2018 - 2030 (USD Million)
      • 7.2.2.2 U.S. 3D Bioprinting market, by application, 2018 - 2030 (USD Million)
    • 7.2.3 Canada
      • 7.2.3.1 Canada 3D Bioprinting market, by technology, 2018 - 2030 (USD Million)
      • 7.2.3.2 Canada 3D Bioprinting market, by application, 2018 - 2030 (USD Million)
  • 7.3 Europe
    • 7.3.1 Europe 3D Bioprinting market, 2018 - 2030 (USD Million)
    • 7.3.2 U.K.
      • 7.3.2.1 U.K. 3D Bioprinting market, by technology, 2018 - 2030 (USD Million)
      • 7.3.2.2 U.K. 3D Bioprinting market, by application, 2018 - 2030 (USD Million)
    • 7.3.3 Germany
      • 7.3.3.1 Germany 3D Bioprinting market, by technology, 2018 - 2030 (USD Million)
      • 7.3.3.2 Germany 3D Bioprinting market, by application, 2018 - 2030 (USD Million)
    • 7.3.4 France
      • 7.3.4.1 France 3D Bioprinting market, by technology, 2018 - 2030 (USD Million)
      • 7.3.4.2 France 3D Bioprinting market, by application, 2018 - 2030 (USD Million)
    • 7.3.5 Italy
      • 7.3.5.1 Italy 3D Bioprinting market, by technology, 2018 - 2030 (USD Million)
      • 7.3.5.2 Italy 3D Bioprinting market, by application, 2018 - 2030 (USD Million)
    • 7.3.6 Spain
      • 7.3.6.1 Spain 3D Bioprinting market, by technology, 2018 - 2030 (USD Million)
      • 7.3.6.2 Spain 3D Bioprinting market, by application, 2018 - 2030 (USD Million)
    • 7.3.7 Denmark
      • 7.3.7.1 Denmark 3D Bioprinting market, by technology, 2018 - 2030 (USD Million)
      • 7.3.7.2 Denmark 3D Bioprinting market, by application, 2018 - 2030 (USD Million)
    • 7.3.8 Sweden
      • 7.3.8.1 Sweden 3D Bioprinting market, by technology, 2018 - 2030 (USD Million)
      • 7.3.8.2 Sweden 3D Bioprinting market, by application, 2018 - 2030 (USD Million)
    • 7.3.9 Norway
      • 7.3.9.1 Norway 3D Bioprinting market, by technology, 2018 - 2030 (USD Million)
      • 7.3.9.2 Norway 3D Bioprinting market, by application, 2018 - 2030 (USD Million)
  • 7.4 Asia Pacific
    • 7.4.1 Asia Pacific 3D Bioprinting market, 2018 - 2030 (USD Million)
    • 7.4.2 Japan
      • 7.4.2.1 Japan 3D Bioprinting market, by technology, 2018 - 2030 (USD Million)
      • 7.4.2.2 Japan 3D Bioprinting market, by application, 2018 - 2030 (USD Million)
    • 7.4.3 China
      • 7.4.3.1 China 3D Bioprinting market, by technology, 2018 - 2030 (USD Million)
      • 7.4.3.2 China 3D Bioprinting market, by application, 2018 - 2030 (USD Million)
    • 7.4.4 India
      • 7.4.4.1 India 3D Bioprinting market, by technology, 2018 - 2030 (USD Million)
      • 7.4.4.2 India 3D Bioprinting market, by application, 2018 - 2030 (USD Million)
    • 7.4.5 Thailand
      • 7.4.5.1 Thailand 3D Bioprinting market, by technology, 2018 - 2030 (USD Million)
      • 7.4.5.2 Thailand 3D Bioprinting market, by application, 2018 - 2030 (USD Million)
    • 7.4.6 Australia
      • 7.4.6.1 Australia 3D Bioprinting market, by technology, 2018 - 2030 (USD Million)
      • 7.4.6.2 Australia 3D Bioprinting market, by application, 2018 - 2030 (USD Million)
    • 7.4.7 South Korea
      • 7.4.7.1 South Korea 3D Bioprinting market, by technology, 2018 - 2030 (USD Million)
      • 7.4.7.2 South Korea 3D Bioprinting market, by application, 2018 - 2030 (USD Million)
  • 7.5 Latin America
    • 7.5.1 Latin America 3D Bioprinting market, 2018 - 2030 (USD Million)
    • 7.5.2 Brazil
      • 7.5.2.1 Brazil 3D Bioprinting market, by technology, 2018 - 2030 (USD Million)
      • 7.5.2.2 Brazil 3D Bioprinting market, by application, 2018 - 2030 (USD Million)
    • 7.5.3 Mexico
      • 7.5.3.1 Mexico 3D Bioprinting market, by technology, 2018 - 2030 (USD Million)
      • 7.5.3.2 Mexico 3D Bioprinting market, by application, 2018 - 2030 (USD Million)
    • 7.5.4 Argentina
      • 7.5.4.1 Argentina 3D Bioprinting market, by technology, 2018 - 2030 (USD Million)
      • 7.5.4.2 Argentina 3D Bioprinting market, by application, 2018 - 2030 (USD Million)
    • 7.5.5 Columbia
      • 7.5.5.1 Columbia 3D Bioprinting market, by technology, 2018 - 2030 (USD Million)
      • 7.5.5.2 Columbia 3D Bioprinting market, by application, 2018 - 2030 (USD Million)
  • 7.6 Middle East & Africa (MEA)
    • 7.6.1 Middle East & Africa 3D Bioprinting market, 2018 - 2030 (USD Million)
    • 7.6.2 South Africa
      • 7.6.2.1 South Africa 3D Bioprinting market, by technology, 2018 - 2030 (USD Million)
      • 7.6.2.2 South Africa 3D Bioprinting market, by application, 2018 - 2030 (USD Million)
    • 7.6.3 Saudi Arabia
      • 7.6.3.1 Saudi Arabia 3D Bioprinting market, by technology, 2018 - 2030 (USD Million)
      • 7.6.3.2 Saudi Arabia 3D Bioprinting market, by application, 2018 - 2030 (USD Million)
    • 7.6.4 UAE
      • 7.6.4.1 UAE 3D Bioprinting market, by technology, 2018 - 2030 (USD Million)
      • 7.6.4.2 UAE 3D Bioprinting market, by application, 2018 - 2030 (USD Million)
    • 7.6.5 Kuwait
      • 7.6.5.1 Kuwait 3D Bioprinting market, by technology, 2018 - 2030 (USD Million)
      • 7.6.5.2 Kuwait 3D Bioprinting market, by application, 2018 - 2030 (USD Million)

Chapter 8 Competitive Landscape

  • 8.1 Company Profiles
    • 8.1.1 Envisiontec, Inc.
      • 8.1.1.1 Company overview
      • 8.1.1.2 Product benchmarking
      • 8.1.1.3 Strategic initiatives
    • 8.1.2 Organovo
      • 8.1.2.1 Company overview
      • 8.1.2.2 Financial performance
      • 8.1.2.3 Product benchmarking
      • 8.1.2.4 Strategic initiatives
    • 8.1.3 Inventia Life Science Pty Ltd
      • 8.1.3.1 Company overview
      • 8.1.3.2 Product benchmarking
    • 8.1.4 POIETIS
      • 8.1.4.1 Company overview
      • 8.1.4.2 Product benchmarking
      • 8.1.4.3 Strategic initiatives
    • 8.1.5 VIVAX BIO, LLC
      • 8.1.5.1 Company overview
      • 8.1.5.2 Product benchmarking
      • 8.1.5.3 Strategic initiatives
    • 8.1.6 ALLEVI
      • 8.1.6.1 Company overview
      • 8.1.6.2 Product benchmarking
    • 8.1.7 Cyfuse Biomedical K.K.
      • 8.1.7.1 Company overview
      • 8.1.7.2 Product benchmarking
      • 8.1.7.3 Strategic initiatives
    • 8.1.8 3D Bioprinting Solutions
      • 8.1.8.1 Company overview
      • 8.1.8.2 Product benchmarking
    • 8.1.9 CELLINK GLOBAL
      • 8.1.9.1 Company overview
      • 8.1.9.2 Financial performance
      • 8.1.9.3 Product benchmarking
      • 8.1.9.4 Strategic initiatives
    • 8.1.10 REGEMAT 3D S.L.
      • 8.1.10.1 Company overview
      • 8.1.10.2 Product benchmarking

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 QFD modeling for market share assessment
  • Fig. 6 Market formulation & validation
  • Fig. 7 3D bioprinting market snapshot (2022)
  • Fig. 8 Market segmentation
  • Fig. 9 Market driver relevance analysis (Current & future impact)
  • Fig. 10 Market restraint relevance analysis (Current & future impact)
  • Fig. 11 Porter's five forces analysis
  • Fig. 12 SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 13 3D bioprinting market technology outlook: Segment dashboard
  • Fig. 14 3D bioprinting market: Technology movement analysis
  • Fig. 15 Magnetic levitation market, 2018 - 2030 (USD Million)
  • Fig. 16 Inkjet-based market, 2018 - 2030 (USD Million)
  • Fig. 17 Syringe-based market, 2018 - 2030 (USD Million)
  • Fig. 18 Laser-based market, 2018 - 2030 (USD Million)
  • Fig. 19 Others market, 2018 - 2030 (USD Million)
  • Fig. 20 3D bioprinting market application outlook: Segment dashboard
  • Fig. 21 3D bioprinting market: Application movement analysis
  • Fig. 22 Medical market, 2018 - 2030 (USD Million)
  • Fig. 23 Tissue and organ generation market, 2018 - 2030 (USD Million)
  • Fig. 24 Medical pills market, 2018 - 2030 (USD Million)
  • Fig. 25 Prosthetic and implants market, 2018 - 2030 (USD Million)
  • Fig. 26 Other medical application market, 2018 - 2030 (USD Million)
  • Fig. 27 Dental market, 2018 - 2030 (USD Million)
  • Fig. 28 Biosensors market, 2018 - 2030 (USD Million)
  • Fig. 29 Consumer/personal product testing market, 2018 - 2030 (USD Million)
  • Fig. 30 Bioinks market, 2018 - 2030 (USD Million)
  • Fig. 31 Food and animal product market, 2018 - 2030 (USD Million)
  • Fig. 32 Regional market: Key takeaways
  • Fig. 33 Regional outlook, 2022 & 2030
  • Fig. 34 North America market, 2018 - 2030 (USD Million)
  • Fig. 35 U.S. market, 2018 - 2030 (USD Million)
  • Fig. 36 Canada market, 2018 - 2030 (USD Million)
  • Fig. 37 Europe market, 2018 - 2030 (USD Million)
  • Fig. 38 U.K. market, 2018 - 2030 (USD Million)
  • Fig. 39 Germany market, 2018 - 2030 (USD Million)
  • Fig. 40 France market, 2018 - 2030 (USD Million)
  • Fig. 41 Italy market, 2018 - 2030 (USD Million)
  • Fig. 42 Spain market, 2018 - 2030 (USD Million)
  • Fig. 43 Denmark market, 2018 - 2030 (USD Million)
  • Fig. 44 Sweden market, 2018 - 2030 (USD Million)
  • Fig. 45 Norway market, 2018 - 2030 (USD Million)
  • Fig. 46 Asia Pacific market, 2018 - 2030 (USD Million)
  • Fig. 47 Japan market, 2018 - 2030 (USD Million)
  • Fig. 48 China market, 2018 - 2030 (USD Million)
  • Fig. 49 India market, 2018 - 2030 (USD Million)
  • Fig. 50 Thailand market, 2018 - 2030 (USD Million)
  • Fig. 51 Australia market, 2018 - 2030 (USD Million)
  • Fig. 52 South Korea market, 2018 - 2030 (USD Million)
  • Fig. 53 Latin America market, 2018 - 2030 (USD Million)
  • Fig. 54 Brazil market, 2018 - 2030 (USD Million)
  • Fig. 55 Mexico market, 2018 - 2030 (USD Million)
  • Fig. 56 Argentina market, 2018 - 2030 (USD Million)
  • Fig. 57 Colombia market, 2018 - 2030 (USD Million)
  • Fig. 58 MEA market, 2018 - 2030 (USD Million)
  • Fig. 59 South Africa market, 2018 - 2030 (USD Million)
  • Fig. 60 Saudi Arabia market, 2018 - 2030 (USD Million)
  • Fig. 61 UAE market, 2018 - 2030 (USD Million)
  • Fig. 62 Kuwait market, 2018 - 2030 (USD Million)